Literature DB >> 12614845

Distribution and breakdown of labeled coenzyme Q10 in rat.

Magnus Bentinger1, Gustav Dallner, Tadeusz Chojnacki, Ewa Swiezewska.   

Abstract

Radioactive coenzyme Q(10) ([(3)H]CoQ) was synthesized in a way that the metabolites produced retained the radioactivity. Administration of the lipid to rats intraperitoneally resulted in an efficient uptake into the circulation, with high concentrations found in spleen, liver, and white blood cells; lower concentrations in adrenals, ovaries, thymus, and heart; and practically no uptake in kidney, muscle, and brain. In liver homogenate most [(3)H]CoQ appeared in the organelles, but it was also present in the cytosol and transport vesicles. Mitochondria, purified on a metrizamide gradient, had a very low concentration of [(3)H]CoQ, which was mainly present in the lysosomes. All organs that took up the labeled lipid also contained water-soluble metabolites. The majority of metabolites excreted through the kidney and appeared in the urine. Some metabolites were also present in the feces, which further contained nonmetabolized [(3)H]CoQ, excreted through the bile. The major metabolites were purified from the urine, and the mass spectrometric fragmentation showed that these compounds, containing the ring with a short side chain, are phosphorylated. Thus, the results demonstrate that CoQ is metabolized in all tissues, the metabolites are phosphorylated in the cells, transported in the blood to the kidney, and excreted into the urine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614845     DOI: 10.1016/s0891-5849(02)01357-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  31 in total

Review 1.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

Review 2.  Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.

Authors:  Josh Lister; José N Nobrega; Paul J Fletcher; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

3.  176th ENMC International Workshop: diagnosis and treatment of coenzyme Q₁₀ deficiency.

Authors:  Shamima Rahman; Catherine F Clarke; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2011-07-01       Impact factor: 4.296

4.  Pathomechanisms in coenzyme q10-deficient human fibroblasts.

Authors:  Luis C López; Marta Luna-Sánchez; Laura García-Corzo; Catarina M Quinzii; Michio Hirano
Journal:  Mol Syndromol       Date:  2014-07

Review 5.  Biochemistry of Mitochondrial Coenzyme Q Biosynthesis.

Authors:  Jonathan A Stefely; David J Pagliarini
Journal:  Trends Biochem Sci       Date:  2017-09-17       Impact factor: 13.807

Review 6.  Coenzyme Q and mitochondrial disease.

Authors:  Catarina M Quinzii; Michio Hirano
Journal:  Dev Disabil Res Rev       Date:  2010

7.  Nutrition in Pediatric Cardiomyopathy.

Authors:  Tracie L Miller; Daniela Neri; Jason Extein; Gabriel Somarriba; Nancy Strickman-Stein
Journal:  Prog Pediatr Cardiol       Date:  2007-11

8.  Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects.

Authors:  Luis C López; Catarina M Quinzii; Estela Area; Ali Naini; Shamima Rahman; Markus Schuelke; Leonardo Salviati; Salvatore Dimauro; Michio Hirano
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

9.  Prolonged intake of coenzyme Q10 impairs cognitive functions in mice.

Authors:  Nathalie Sumien; Kevin R Heinrich; Ritu A Shetty; Rajindar S Sohal; Michael J Forster
Journal:  J Nutr       Date:  2009-08-26       Impact factor: 4.798

Review 10.  Coenzyme Q, oxidative stress and aging.

Authors:  Rajindar S Sohal; Michael J Forster
Journal:  Mitochondrion       Date:  2007-03-30       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.